The challenges scientists encountered when trying to develop a better flu vaccine are reported in a paper published on January 23rd in iPLOS Pathogens/i. Because immune systems in older people are generally less responsive to vaccination, Jay Evans and colleagues from GlaxoSmithKline Vaccines in Hamilton, USA, were testing so-called adjuvants-vaccine components that provoke a stronger immune reaction-that could be added to the regular flu vaccine cocktail to ...
Read More
No comments:
Post a Comment